Canada markets open in 3 hours 46 minutes
  • S&P/TSX

    -194.95 (-1.06%)
  • S&P 500

    -51.25 (-1.34%)
  • DOW

    -345.95 (-1.11%)

    -0.0029 (-0.37%)

    +1.25 (+1.96%)

    -2,997.81 (-4.78%)
  • CMC Crypto 200

    -48.13 (-4.87%)

    -7.70 (-0.45%)
  • RUSSELL 2000

    -60.87 (-2.76%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • NASDAQ futures

    -62.75 (-0.50%)

    +1.71 (+6.41%)
  • FTSE

    +7.76 (+0.12%)
  • NIKKEI 225

    -65.79 (-0.23%)

    -0.0005 (-0.08%)

Skylight Health Receives Conditional Approval of TSX Venture Listing

Skylight Health Group Inc.
·4 min read
  • Skylight Health has been granted conditional approval for listing on the TSX Venture Exchange

  • Company expects to commence trading on the TSX Venture in January 2021

  • Company will continue to trade under the symbol “SHG” on the TSX Venture

TORONTO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (CSE:SHG; OTCQX:SHGFF) (“SHG” or the “Company”), one of the largest multi-specialty healthcare systems in the United States, is pleased to announce that it has received conditional approval to list its common shares on the TSX Venture Exchange (“TSX-V”), and will concurrently delist its common shares from the Canadian Securities Exchange (“CSE”). To ensure continued trading of the Company’s common shares, the Company intends to seamlessly arrange for the simultaneous delisting of its common shares from the CSE and subsequent commencement of trading on the TSX-V.

"Graduating to the TSX-V is yet another milestone achieved as we continue to execute our focused growth plan of becoming one of the largest US integrated healthcare systems," said Prad Sekar, CEO of Skylight Health. "We look forward to the TSX-V providing us a larger platform for growth, institutional coverage and border liquidity as we continue to aggressively execute against our 2021 business plan."

Skylight Health’s common shares will trade on the TSX Venture under symbol “SHG”.

The Company has also issued 500,000 options at a price of $1.11 to certain consultants for services delivered.

About Skylight Health Group

Skylight Health Group (CSE:SHG OTCQX:SHGFF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state health network that comprises of physical multi-disciplinary medical clinics providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations. healthcare services. With a patient roster of over 120,000 patients, the Company’s operations spread across 14 states and continues to expand in services and locations both organically and by way of strategic acquisitions.

The Company primarily operates a traditional insurable fee-for-service model contracting with Medicare, Medicaid and other Commercial Payors. The Company also offers a disruptive subscription-based telemedicine service for the un/under-insured population who have limited access to urgent care due to cost.

For more information, please visit or contact:

Investor Relations
Jonathan L. Robinson CFA
Oak Hill Financial

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health’s filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements regarding the Company’s unaudited financial results and projected growth.

Although Skylight Health as attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are subject to inconsistent legislation and regulation; change in laws; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and recreational-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.

No securities regulator or exchange has reviewed, approved, disapproved, or accepts responsibility for the content of this news release.